Literature DB >> 12567336

Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model.

Leanne Groban1.   

Abstract

With the development of the newer long-acting amide local anesthetics,ropivacaine and levobupivacaine, numerous animal studies of LA systemic toxicity have emerged. Because of the complex nature of the human response to LA intoxication, the task of designing and interpreting these animal studies of LA toxicity can be difficult. Accordingly, this report will review the selection of an animal model for the study of LA toxicity; examine the pertinent in vivo animal studies that compare the central nervous system toxicity, cardiovascular toxicity, and the ease of resuscitation of the single enantiomer local anesthetics to racemic bupivacaine; and extrapolate these findings to the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12567336     DOI: 10.1053/rapm.2003.50014

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  18 in total

1.  Scavenging nanoparticles: an emerging treatment for local anesthetic toxicity.

Authors:  Elizabeth M Renehan; F Kayser Enneking; Manoj Varshney; Richard Partch; Donn M Dennis; Timothy E Morey
Journal:  Reg Anesth Pain Med       Date:  2005 Jul-Aug       Impact factor: 6.288

Review 2.  Anaesthetic agents for advanced regional anaesthesia: a North American perspective.

Authors:  Chester C Buckenmaier; Lisa L Bleckner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Lipid emulsion mitigates local anesthesia-induced central nervous system toxicity in rats.

Authors:  Gangming Wu; Bin Sun; L I Liu; Jun Zhou; Liqun Mo; Changhe Ren; Cehua Ou
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

4.  The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.

Authors:  Hye Won Shin; Jeong Seop Soh; Hee Zoo Kim; Jinpyo Hong; Dong Ho Woo; Jun Young Heo; Eun Mi Hwang; Jae-Yong Park; C Justin Lee
Journal:  J Anesth       Date:  2014-02       Impact factor: 2.078

5.  Injectable electrospun fiber-hydrogel composite sequentially releasing clonidine and ropivacaine for prolonged and walking regional analgesia.

Authors:  Sufang Chen; Weifeng Yao; Haixia Wang; Tienan Wang; Xue Xiao; Guoliang Sun; Jing Yang; Yu Guan; Zhen Zhang; Zhengyuan Xia; Mingqiang Li; Yu Tao; Ziqing Hei
Journal:  Theranostics       Date:  2022-06-21       Impact factor: 11.600

Review 6.  Ambroxol: a CNS drug?

Authors:  Thomas Weiser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

7.  Comparison of preincisional infiltrated levobupivacaine and ropivacaine for acute postoperative pain relief after septorhinoplasty.

Authors:  Cihangir Bicer; Teoman Eskıtascıoglu; Recep Aksu; Ayse Ulgey; Karamehmet Yildiz; Halit Madenoglu
Journal:  Curr Ther Res Clin Exp       Date:  2011-02

Review 8.  A Review of Regional Anesthesia in Infants.

Authors:  Karen R Boretsky
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

9.  Formulation and evaluation of multilamellar vesicles ropivacaine in pain management.

Authors:  Hao-Wen Kao; Yi-Yu Lin; Walter J Gwathney; Keelung Hong
Journal:  Int J Nanomedicine       Date:  2019-09-27

10.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.